Frontiers in pharmacology

Front Pharmacol · ISSN (print) 1663-9812 · 238 papers in corpus
2026
doi:10.3389/fphar.2026.1797204 ·PMID:42272838

BackgroundClinical pharmacology teaching is often limited by abstract content and insufficient integration of anatomical structure, physiological regulation, and drug targets. Traditional teaching models make it difficult for interns to tra…

2026
doi:10.3389/fphar.2026.1797636 ·PMID:42465988

IntroductionThe female reproductive tract (FRT) is underrepresented in Physiologically-Based Pharmacokinetic (PBPK) models, creating a critical gap for data-driven, female-specific decision-making. To address this gap, a PBPK model extensio…

2026
doi:10.3389/fphar.2026.1839523 ·PMID:42239515

ObjectiveTo investigate the expression pattern, diagnostic value, and molecular mechanism of CCAAT/enhancer-binding protein delta (CEBPD) in uterine leiomyoma (ULM)-associated fibrosis, and to identify novel diagnostic biomarkers and therap…

article 2026
doi:10.3389/fphar.2026.1860816 ·PMID:42328640

BACKGROUND: Elagolix and Myfembree are gonadotropin-releasing hormone (GnRH)-pathway therapies used for endometriosis, but their post-marketing safety reporting patterns remain incompletely characterized. Because spontaneous reporting datab…

2026
doi:10.3389/fphar.2026.1831561 ·PMID:42499487

BackgroundBojungikki-tang (Buzhongyiqi decoction, Hochuekkito, BIT) has been used in East Asian medicine for conditions with fatigue, reduced appetite, and functional decline. In recent years, research on this preparation has expanded acros…

2026
doi:10.3389/fphar.2026.1844087 ·PMID:42305441

Chronic pain is increasingly recognized as a multidimensional condition in which neuroimmune interactions shape disease vulnerability and persistence. Among the emerging pain phenotypes, nociplastic pain (defined as an alteration of nocicep…

2026
doi:10.3389/fphar.2026.1878277 ·PMID:42568500

Metabolic dysfunction-associated steatotic liver disease (MASLD) has become the most prevalent chronic liver disease worldwide, yet no pharmacological therapy has achieved regulatory approval. Flavonoids, plant-derived polyphenols encompass…

review 2026
doi:10.3389/fphar.2026.1897505 ·PMID:42774715

Endometriosis is a chronic, heterogeneous gynaecological disorder characterised by the presence of endometrial-like tissue outside the uterine cavity and is associated with pain, infertility, and reduced quality of life. Emerging evidence s…

2026
doi:10.3389/fphar.2026.1882659 ·PMID:42666415

IntroductionCordyline terminalis is an important ornamental and medicinal plant valued for its antioxidant, antimicrobial, anti-inflammatory, antiproliferative, hypolipidemic, and wound-healing activities outcomes. Biochar is a carbonaceous…

2026
doi:10.3389/fphar.2026.1905013 ·PMID:42729152

ObjectivePer- and polyfluoroalkyl substances (PFAS) are omnipresent, persistent contaminants associated with rising ovarian cancer incidence; however, the molecular circuitry linking PFAS to ovarian tumorigenesis remains obscure.MethodsHere…

review 2026
doi:10.3389/fphar.2026.1742212 ·PMID:41693781

Endometriosis (EMs) is a gynecological inflammatory disease that depends on estrogen. Its chief symptoms include dysmenorrhea, chronic pelvic pain, reduced fertility, and pelvic masses. Although various hormonal therapies and surgical treat…

2026
doi:10.3389/fphar.2026.1722249 ·PMID:41737550

BackgroundIn 2020, South Korea's National Health Insurance (NHI) began reimbursing individually prescribed herbal medicine decoctions (HMDs) for dysmenorrhea, highlighting the need for robust post-coverage safety monitoring using national c…

review 2026
doi:10.3389/fphar.2026.1768006 ·PMID:41821610

Female reproductive disorders represent a major global health challenge. Despite their clinical heterogeneity, these conditions share core pathological mechanisms including oxidative stress, chronic inflammation, hormonal imbalance, metabol…

review 2026
doi:10.3389/fphar.2026.1767202 ·PMID:42367289

BACKGROUND: Adenomyosis occurs when tissue from the inner lining of the endometrium grows into the muscle wall of the myometrium. Previous studies have suggested that High-Intensity Focused Ultrasound (HIFU) combined with medications may im…

2026
doi:10.3389/fphar.2026.1617484 ·PMID:42158955

BackgroundOvarian cancer (OC) remains the most lethal gynecological malignancy, with platinum sensitivity being a key determinant of treatment outcomes. The KELIM model, derived from CA-125 kinetics, is a promising biomarker for predicting …

2026
doi:10.3389/fphar.2026.1849299 ·PMID:42756751

Vitamin D has attracted increasing attention in male reproduction, male fertility, and sperm function, but its pharmacological relevance remains incompletely defined. This review synthesizes current evidence on the molecular mechanisms and …

other 2025
doi:10.3389/fphar.2025.1716062 ·PMID:41415567

BACKGROUND: Endometriosis is a chronic, heterogeneous disease with limited non-hormonal treatment options. Drug repurposing provides an accelerated route to identify safe, tolerable, and potentially effective therapies for endometriosis. Re…

2025
doi:10.3389/fphar.2025.1649041 ·PMID:40786055

ObjectiveWhether large language models (LLMs) can effectively facilitate CM knowledge acquisition remains uncertain. This study aims to assess the adherence of LLMs to Clinical Practice Guidelines (CPGs) in CM.MethodsThis cross-sectional st…

2025
doi:10.3389/fphar.2025.1607349 ·PMID:40709089

BackgroundT cells are contributors to atherosclerosis pathogenesis. Granulocyte-macrophage-colony-stimulating factor (GM-CSF)-producing T helper (ThGM) cells, a specialized helper T cell subset that highly expresses GM-CSF but lacks other h…

2025
doi:10.3389/fphar.2025.1552581 ·PMID:40191422

ObjectiveTo investigate the efficacy of the Er Zhi Tian Gui Formula (EZTGF) in diminished ovarian reserve (DOR) patients undergoing in vitro fertilization-embryo transfer (IVF-ET); to examine the pharmacological mechanism of EZTGF in inhibi…

2025
doi:10.3389/fphar.2025.1702273 ·PMID:41458961

Ovarian cancer, particularly epithelial ovarian cancer (EOC), is the most aggressive and lethal gynecologic malignancy, necessitating the development of innovative and potent therapies to improve its prognosis. Human polo-like kinase 1 (PLK…

other 2025
doi:10.3389/fphar.2025.1702257 ·PMID:41573738

BACKGROUND: Spironolactone, eplerenone, and finerenone are three commonly used mineralocorticoid receptor antagonists (MRAs) with cardioprotective and renoprotective effects. However, comparative real-world safety evaluations remain limited…

other 2025
doi:10.3389/fphar.2025.1691279 ·PMID:41341035

Endometriosis (EMs) is an estrogen-dependent chronic inflammatory disease. While apoptosis resistance (evidenced by Bcl-2 upregulation and Bax/caspase-3 downregulation) remains a hallmark of EMs, recent studies reveal a paradoxical coexiste…

2025
doi:10.3389/fphar.2025.1556196 ·PMID:40786052

CXC chemokine receptor 3 (CXCR3) is a G protein-coupled chemokine receptor that plays a key role in regulating immune responses and is involved in various pathological processes, particularly in tumor development and inflammatory diseases, …